TLR3 and neoplasm: TLR3‐poly I:C interaction also enhances the therapeutic value of the conventional antitumour agent cycloheximide in different human and murine tumour cell lines through increasing the production of IFN‐γ, a well‐known cytokine which its association with caspase and p53 has been previously well‐established.77